argenx SE

Contributing Author

Recent Articles by argenx SE

Aug-28	argenx to Present at Upcoming Investor Conferences ARGX GlobeNewswire
Aug-25	argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG ARGX GlobeNewswire
Aug-19	argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025 ARGX GlobeNewswire
Aug-12	argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis ARGX GlobeNewswire
Jul-31	argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update ARGX GlobeNewswire
Jul-24	argenx to Report Half Year 2025 Financial Results and Second Quarter Business Update on July 31, 2025 ARGX GlobeNewswire
Jun-30	argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes ARGX GlobeNewswire
Jun-20	argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy ARGX GlobeNewswire
Jun-10	argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease ARGX GlobeNewswire
Jun-03	argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference ARGX GlobeNewswire
May-28	argenx Announces Results of Annual General Meeting of Shareholders ARGX GlobeNewswire
May-08	argenx Reports First Quarter 2025 Financial Results and Provides Business Update ARGX GlobeNewswire
May-06	argenx to Present at BofA Securities 2025 Health Care Conference ARGX GlobeNewswire